This AI Stock Is Down 48% From 52-Week High – Death Cross Signals Further Trouble Ahead – C3.ai (NYSE:AI)

Photo of author

By Ronald Tech

C3.ai Inc. AI investors just got another bearish signal—the ominous Death Cross. The artificial intelligence software company’s stock has plummeted 32.25% year-to-date and 10.79% over the past month.

Now, the technical outlook suggests more downside ahead, even as AI hype remains strong.

Read Also: C3.ai Sees Stronger Revenue But Analyst Concerned Over Profitability And Scale

C3.AI Stock Chart Paints A Bearish Technical Picture

Chart created using Benzinga Pro

C3.ai stock, at $23.49, is trading well below key moving averages, confirming a strongly bearish trend despite some minor buying pressure. The eight-day simple moving average at $22.22 and the 20-day simple moving average at $22.61 offer bullish signals, but the broader technical picture remains negative:

  • 50-day simple moving average: $28.26 (bearish signal)
  • 200-day simple moving average: $28.51 (bearish signal)
  • Moving Average Convergence Divergence (MACD): negative 1.76 (bearish momentum)
  • Relative Strength Index (RSI): 44.26 (weak momentum, not yet oversold)

Investors should be wary of further declines with the Death Cross confirming a sustained downtrend.

AI Optimism Vs. Technical Weakness

Despite the stock’s struggles, artificial intelligence remains a major growth theme.

Technicals indicate that C3.ai is not yet positioned for a bullish reversal.

Until momentum shifts, investors should approach cautiously, watching for signs of stabilization before making any bullish bets.

Investor Takeaway

C3.ai is nearly 48% below its 52-week high, and the Death Cross suggests more volatility ahead.

While AI remains an exciting sector, this stock’s technicals point to further downside risk. Investors should monitor key resistance levels and wait for clearer signs of strength before considering a position.

Read Next:

See also  Opportunity for LFCR Investors in Lifecore Biomedical, Inc. Securities Fraud LawsuitUnveiling the Curtain: Lifecore Biomedical Investor's Gibbet to Swing?

Photo: Shutterstock

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Momentum29.25

Growth60.94

Quality

Value52.98

Market News and Data brought to you by Benzinga APIs